The Enchilada

4 OpsisDx Tests Licensed in the USA

Entopsis recently signed licensing agreements with a CLIA-certified diagnostic laboratory to commercialize 4 oncology OpsisDx tests in the USA. This represents the first step in bringing OpsisDx to market.

The Entopsis team continues to prove-out the capabilities of OpsisDx for the early detection of other cancers, infectious diseases and mental illnesses. These efforts are aimed at establishing additional partnerships globally for a variety of medical conditions so that we can offer better health outcomes to all people.

OpsisDx Detects 5 Cancers & HepB from Urine

Preliminary results are in from the on-going international clinical study exploring the ability of OpsisDx to accurately identify people with multiple diseases.

Highlights:

  1. OpsisDx distinguishes between people with cancer, hepatitis B viral and healthy controls
  2. OpsisDx accurately identifies patient’s cancer tissue of origin (lung, prostate, breast, liver or colorectal)
  3. Hepatitis B viral infection, often linked to increased likelihood for liver cancer, is observed as a distinct category from liver cancer patients
  4. OpsisDx detects more stage I cancers than liquid biopsies as performed by GRAIL

OpsisDx Distinguishes Between Analytes with ~100% Accuracy

Can OpsisDx distinguish between similar molecules? Let’s say between different salts or isomers of carrageenan or phenol vs cresol?

YES … we observe distinct NuTec profiles for each molecule or mixture, even for molecules with similar structures.

This provides a framework for people to better grasp the inner workings of OpsisDx.

New Robot Joins the Entopsis Team

We are obsessed with efficiency and committed to manufacturing in the U.S. all critical OpsisDx components.

Our NuTec Slide manufacturing team incorporates a new robot to the manufacturing process. This addition, plus updates to current automated manufacturing processes, more than quadruples our manufacturing capabilities. These updates set the ground work for future scale-up efforts.

Gen 4 NuTec Slides Complete

Our team of scientists have completed a re-design of the NuTec Slide based on our continued research into this new field. This latest version offers increased reproducibility and stability. The generation 4 NuTec Slide will be used in an international, multi-disease study.

Page3of3